Tertiary pain-clinic records show mixed erythromelalgia treatment responses
Erythromelalgia in a tertiary pain clinic: a comprehensive database study of clinical features and treatment experience.
AI Summary
This observational database study examined clinical features and documented treatment experiences among 23 people with erythromelalgia identified in a tertiary pain clinicβs records. Symptoms and diagnostic certainty varied: burning pain was documented in 16/23, while erythema or warmth was documented in 17/23. The studyβs main treatment finding was that commonly used oral therapies more often had records of no benefit or intolerance than benefit. For cannabis, benefit was documented in 6/9 cases, but the reported benefit was often nonspecific.
Intravenous lidocaine-magnesium was documented as beneficial in 5/8 cases, usually with transient effects; no recorded feature clearly separated patients with and without benefit. Because this was a small review of clinical records, and treatment responses were not assessed in a controlled comparison, the findings cannot establish which treatments work best or prove that cannabis was responsible for reported benefit. This is an abstract-based summary; the study does not establish comparative efficacy.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Pain research papers you might find interesting.
TBI study links cannabis use with symptoms, not proven effects
Small ALS trial found no significant disease-progression difference
Review finds strongest evidence in select seizure and MS symptoms
Explore More Research
Stay informed about the latest cannabis science.